IMM Immupharma Plc

 

TIDMIMM 
 
RNS Number : 7193U 
Immupharma PLC 
30 June 2009 
 

+------------------------------------+------------------------------------+ 
| For Immediate Release              |                       30 June 2009 | 
+------------------------------------+------------------------------------+ 
 
 
 
 
ImmuPharma PLC 
 
Annual Report and Accounts 
 
 
In accordance with Rule 20 of the AIM Rules, ImmuPharma PLC (AIM:IMM), the 
specialist drug discovery and development company, confirms that the Annual 
Report and Accounts for the year ended 31 December 2008, has been posted to 
shareholders. 
 
 
The annual report is available, in electronic form, for download on the 
Company's website www.immupharma.com. 
 
 
The Company's Annual General Meeting will be held on 24 July 2009 at 11am at 50 
Broadway, London, SW1H 0BL. 
 
Ends 
 
 
For further information please contact: 
 
 
+------------------------------------+------------------------------------+ 
| ImmuPharma PLC:                    |                                    | 
+------------------------------------+------------------------------------+ 
| Dimitri Dimitriou, Chief Executive |                   +44 20 7152 4080 | 
| Officer                            |                                    | 
+------------------------------------+------------------------------------+ 
| Richard Warr, Chairman             |                   +44 20 7152 4080 | 
+------------------------------------+------------------------------------+ 
|                                    |                                    | 
+------------------------------------+------------------------------------+ 
| Buchanan Communications            |                  + 44 20 7466 5000 | 
+------------------------------------+------------------------------------+ 
| Lisa Baderoon                      |                                    | 
+------------------------------------+------------------------------------+ 
| Rebecca Skye Dietrich              |                                    | 
+------------------------------------+------------------------------------+ 
|                                    |                                    | 
+------------------------------------+------------------------------------+ 
| Panmure Gordon & Co                |                                    | 
+------------------------------------+------------------------------------+ 
| Andrew Burnett                     |                   +44 151 243 0963 | 
+------------------------------------+------------------------------------+ 
|                                    |                                    | 
+------------------------------------+------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 ACSFLMFTMMMTBPL 
 

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024

Immupharma (LSE:IMM)
Historical Stock Chart
From Jul 2023 to Jul 2024